telocinobufagin has been researched along with Lung-Neoplasms* in 1 studies
1 review(s) available for telocinobufagin and Lung-Neoplasms
Article | Year |
---|---|
Telocinobufagin Has Antitumor Effects in Non-Small-Cell Lung Cancer by Inhibiting STAT3 Signaling.
Non-small-cell lung carcer (NSCLC), the main histological subtype of lung cancer, is responsible for significant morbidity and mortality worldwide. Telocinobufagin, an active compound of the Chinese traditional medicine ChanSu, has antitumor effects, but its mechanism of action remains unknown. Therefore, we investigated the effect of telocinobufagin on NSCLC growth and metastasis and its possible mechanism of action, Topics: Animals; Apoptosis; Bufanolides; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Lung Neoplasms; Mice; Signal Transduction; STAT3 Transcription Factor | 2022 |